Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
JACC. Cardiovascular Interventions|August 7, 2017
Transcatheter Tricuspid Valve Repair With a New Transcatheter Coaptation System for the Treatment of Severe Tricuspid Regurgitation: 1-Year Clinical and Echocardiographic ResultsGidon Perlman, Fabien Praz, Rishi Puri, et al.
JACC. Cardiovascular Interventions|August 10, 2019
Long-Term Outcomes of the FORMA Transcatheter Tricuspid Valve Repair System for the Treatment of Severe Tricuspid Regurgitation: Insights From the First-in-Human ExperienceLluis Asmarats, Gidon Perlman, Fabien Praz, et al.
JACC. Cardiovascular Imaging|December 17, 2018
Changes in Coronary Plaque Composition in Patients With Acute Myocardial Infarction Treated With High-Intensity Statin Therapy (IBIS-4): A Serial Optical Coherence Tomography StudyLorenz Räber, Konstantinos C Koskinas, Kyohei Yamaji, et al.
American Heart Journal|July 6, 2010
Cell-based therapy for myocardial repair in patients with acute myocardial infarction: rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI)Daniel Sürder, Jürg Schwitter, Tiziano Moccetti, et al.
JAMA|August 23, 2012
Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trialLorenz Räber, Henning Kelbæk, Miodrag Ostojic, et al.
JACC. Cardiovascular Interventions|July 25, 2015
Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention: Results of a Nonrandomized Observational StudyLorenz Räber, Roland Klingenberg, Dik Heg, et al.
Circulation|April 19, 2013
Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular functionDaniel Sürder, Robert Manka, Viviana Lo Cicero, et al.
Lancet (London, England)|September 1, 2018
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trialPascal Vranckx, Marco Valgimigli, Peter Jüni, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 10, 2019
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trialKuniaki Takahashi, Ply Chichareon, Rodrigo Modolo, et al.
Circulation|August 30, 2021
Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled TrialPieter C Smits, Enrico Frigoli, Jan Tijssen, et al.
Pageof 8